A 52-Week, Double-Blind Evaluation of the Metabolic Effects of Aripiprazole and Lithium in Bipolar I Disorder

Introduction: Metabolic risk factors, termed metabolic syndrome, which include obesity, diabetes, dyslipidemia, and hypertension, are more common in patients with bipolar disorder than in the general population. Moreover, medications used to treat bipolar disorder carry some risk of worsening metabo...

Full description

Saved in:
Bibliographic Details
Main Authors: McIntyre, Roger S., McElroy, Susan L., Eudicone, James M., Forbes, Robert A., Carlson, Berit X., Baker, Ross A.
Format: Artigo
Language:Inglês
Published: Physicians Postgraduate Press, Inc. 2011
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3304683/
https://ncbi.nlm.nih.gov/pubmed/22454801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/PCC.11m01182
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items